Dr. Baumgartner joins Applied as an accomplished global drug development leader with over 35 years of experience in senior regulatory, clinical development, and medical affairs roles. He has held a ...

Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings ...

The decision not to approve the drug was met with consternation by the Galactosemia Foundation, which represents patients with the disorder, and which called the outcome "devastating." There are ...

After hours: March 18 at 7:59:01 PM EDT Loading Chart for APLT ...